MBL Wealth
RPRX icon

MBL Wealth’s Royalty Pharma RPRX Stock Holding History

MBL Wealth’s Portfolio RPRX Stock Details RPRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$228K Buy
3,908
+266
+7% +$15.7K 0.01% 551
2026
Q2 		$204K Buy
+3,642
New +$190K 0.01% 374

Other funds holding RPRX

Capital International Investors
Capital International Investors Los Angeles, California $483B AUM 27.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $118B AUM 40.52% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $106B AUM 2.29% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $824B AUM 37.44% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.27T AUM 50.62% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $179B AUM 29.92% 1-Year Est. Return
Royal London Asset Management
Royal London Asset Management United Kingdom $54.5B AUM 31.87% 1-Year Est. Return

MBL Wealth's RPRX Position: Q3 2026 in Review

MBL Wealth increased its Royalty Pharma (RPRX) stake by 7.3% in Q3 2026, buying an estimated $15.7K and bringing the position to 3,908 shares worth $228K. The position accounts for 0.01% of the portfolio, ranked #551.

MBL Wealth first reported a position in RPRX in Q2 2026 and has held it in 2 quarters since. 526 funds tracked by Wall St. Rank hold RPRX as of Q3 2026.

  • MBL Wealth held 3,908 shares of Royalty Pharma worth $228K as of Q3 2026.
  • MBL Wealth bought 266 Royalty Pharma shares in Q3 2026, an estimated $15.7K.
  • Royalty Pharma made up 0.01% of MBL Wealth's portfolio in Q3 2026, its #551 holding.
  • MBL Wealth first reported a position in Royalty Pharma in Q2 2026 and has held it in 2 quarters since.
  • 526 funds tracked by Wall St. Rank held Royalty Pharma as of Q3 2026.

Based on MBL Wealth's 13F filing for Q3 2026, filed 22 Oct 2026.